AR079750A2 - Comprimidos bucodispersables y metodo de fabricacion - Google Patents

Comprimidos bucodispersables y metodo de fabricacion

Info

Publication number
AR079750A2
AR079750A2 ARP100104958A ARP100104958A AR079750A2 AR 079750 A2 AR079750 A2 AR 079750A2 AR P100104958 A ARP100104958 A AR P100104958A AR P100104958 A ARP100104958 A AR P100104958A AR 079750 A2 AR079750 A2 AR 079750A2
Authority
AR
Argentina
Prior art keywords
active pharmaceutical
pharmaceutical component
sponsible
tablets
manufacturing
Prior art date
Application number
ARP100104958A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37546630&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR079750(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR079750A2 publication Critical patent/AR079750A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives

Abstract

Reivindicacion 1: Un comprimido bucodispersable que tiene una dureza de al menos 22 N y un tiempo de desintegracion bucal de menos de 120 seg y que comprende un componente farmacéutico activo que se adsorbe en un relleno hidrosoluble, uno o más desintegrantes y opcionalmente relleno hidrosoluble adicional, donde dicho componente farmacéutico activo tiene un punto de fusion en el rango de 40-100sC. Reivindicacion 3: Un comprimido bucodispersable de acuerdo con la reivindicacion 1 o 2, que se caracteriza en que el componente farmacéutico activo se selecciona del grupo que consiste en escitalopram, etosuximida, trimetadiona, clorambucilo, disulfiram, fenofibrato, guaifenesina, lomustina, carisoprodol y perfenacina.
ARP100104958A 2005-06-22 2010-12-27 Comprimidos bucodispersables y metodo de fabricacion AR079750A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200500912 2005-06-22

Publications (1)

Publication Number Publication Date
AR079750A2 true AR079750A2 (es) 2012-02-15

Family

ID=37546630

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP060102654A AR055062A1 (es) 2005-06-22 2006-06-21 Base cristalina de escitalopram y comprimidos bucodispersables que comprenden una base de escitalopram
ARP100104958A AR079750A2 (es) 2005-06-22 2010-12-27 Comprimidos bucodispersables y metodo de fabricacion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP060102654A AR055062A1 (es) 2005-06-22 2006-06-21 Base cristalina de escitalopram y comprimidos bucodispersables que comprenden una base de escitalopram

Country Status (39)

Country Link
EP (3) EP2385044A1 (es)
JP (5) JP4906852B2 (es)
KR (5) KR20080018191A (es)
CN (2) CN101928269A (es)
AR (2) AR055062A1 (es)
AT (3) AT10983U1 (es)
AU (2) AU2006261452B2 (es)
BG (1) BG66086B1 (es)
BR (1) BRPI0612295A2 (es)
CA (2) CA2612827C (es)
CY (1) CY1112392T1 (es)
CZ (3) CZ299906B6 (es)
DE (2) DE112006001619T5 (es)
DK (3) DK1896439T4 (es)
EA (2) EA201001108A1 (es)
EE (1) EE00773U1 (es)
ES (2) ES2319073B1 (es)
FI (2) FI20077133A (es)
GB (2) GB2442160B (es)
HR (1) HRP20110093T4 (es)
HU (1) HUP0800135A3 (es)
IL (1) IL187454A0 (es)
IS (1) IS8705A (es)
LT (1) LT5550B (es)
LV (1) LV13677B (es)
MX (1) MX2007015328A (es)
MY (2) MY143252A (es)
NO (2) NO20080359L (es)
PL (2) PL1896439T5 (es)
PT (1) PT1896439E (es)
RS (1) RS51575B2 (es)
SG (1) SG169358A1 (es)
SI (1) SI1896439T2 (es)
SK (1) SK500402007A3 (es)
TR (2) TR200708792T1 (es)
TW (2) TWI347942B (es)
UA (1) UA86536C2 (es)
WO (1) WO2006136169A2 (es)
ZA (2) ZA200711066B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
WO2008104880A2 (en) * 2007-03-01 2008-09-04 Aurobindo Pharma Limited Stable solid dosage forms of an antidepressant
DK2595979T3 (en) 2010-07-23 2016-05-17 Lundbeck & Co As H A process for the purification of pharmaceutically acceptable salts of escitalopram
CN103360353A (zh) * 2013-08-07 2013-10-23 中国药科大学 草酸艾司西酞普兰杂质的制备方法
JP2018016569A (ja) * 2016-07-26 2018-02-01 株式会社トクヤマ （１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
WO2018190294A1 (ja) * 2017-04-10 2018-10-18 東和薬品株式会社 エスシタロプラム医薬組成物
CN110711198B (zh) * 2018-07-12 2022-03-15 山东大学 D-甘露糖在制备抗抑郁药物中的应用
KR102331187B1 (ko) 2019-04-09 2021-11-26 주식회사 라이트팜텍 에스시탈로프람을 함유하는 안정성이 우수한 경구용 액제 조성물 및 그의 제조방법

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
JPH05222041A (ja) * 1992-02-13 1993-08-31 Mitsubishi Gas Chem Co Inc アデニン誘導体の精製法
CN1139877A (zh) * 1994-01-27 1997-01-08 俄克拉何马大学董事会 迅速溶解的口服药剂形式
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
EP0993524B1 (en) 1997-06-30 2002-11-20 Beloit Technologies, Inc. Method and apparatus for the high speed application of coating to a traveling paper web
DK1015416T3 (da) 1997-07-08 2001-11-05 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
JP3813820B2 (ja) 1997-11-11 2006-08-23 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
US20020071864A1 (en) * 1999-03-25 2002-06-13 Yuhan Corporation Rapidly disintegrable tablet for oral administration
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
JP2001226372A (ja) * 1999-12-06 2001-08-21 Sumika Fine Chemicals Co Ltd ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
CA2424770A1 (en) * 2000-10-06 2003-04-03 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation
US20040014680A1 (en) * 2000-10-16 2004-01-22 Hiroaki Nakagami Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same
US7799342B2 (en) 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
CA2360303C (en) * 2000-12-22 2003-08-12 Marco Villa Process for the preparation of pure citalopram
EP1181272B1 (en) * 2000-12-28 2002-08-28 H. Lundbeck A/S Process for the preparation of pure citalopram
US20040198809A1 (en) * 2001-05-01 2004-10-07 Connie Sanchez Use of enantiomeric pure escitalopram
US6872405B2 (en) * 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
GB0113842D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
AR034612A1 (es) * 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
TR200400189T2 (tr) * 2001-07-31 2004-12-21 H.Lundbeck A/S Esitalopram içeren kristal yapılı bileşim.
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
WO2003057132A2 (en) * 2002-01-07 2003-07-17 Sun Pharmaceutical Industries Limited Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
EP2228060A1 (en) * 2002-05-03 2010-09-15 Skyepharma Canada Inc. Oral dosage forms comprising fenofibrate
PT1578738E (pt) 2002-12-23 2008-04-11 Lundbeck & Co As H Bromidrato de escitalopram e um método para a sua preparação
CN1510024A (zh) * 2002-12-24 2004-07-07 北京德众万全药物技术开发有限公司 可用于制备西酞普兰(s)-对映异构体的新的化合物及其制备方法
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
US7749533B2 (en) * 2003-05-07 2010-07-06 Akina, Inc. Highly plastic granules for making fast melting tablets
IN234086B (es) * 2003-10-15 2009-05-29 Fuji Chem Ind Co Ltd
WO2005049596A1 (en) * 2003-11-20 2005-06-02 Natco Pharma Limited A process for the preparation of high purity escitalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2005084643A1 (en) * 2004-03-05 2005-09-15 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
WO2006106531A1 (en) * 2005-04-04 2006-10-12 Jubilant Organosys Ltd Process for the preparation of escitalopram or its acid addition salts

Also Published As

Publication number Publication date
JP4415056B2 (ja) 2010-02-17
AT11883U1 (de) 2011-06-15
UA86536C2 (ru) 2009-04-27
DK1896439T4 (en) 2015-01-12
HRP20110093T4 (hr) 2015-02-27
EA200800102A1 (ru) 2008-04-28
ES2356838T3 (es) 2011-04-13
TW200740785A (en) 2007-11-01
PL1896439T3 (pl) 2011-04-29
JP5731957B2 (ja) 2015-06-10
CZ301286B6 (cs) 2009-12-30
BG110024A (bg) 2008-05-30
EA201001108A1 (ru) 2011-02-28
HRP20110093T1 (hr) 2011-03-31
BRPI0612295A2 (pt) 2011-01-04
TWI358407B (en) 2012-02-21
TR200708792T1 (tr) 2008-05-21
WO2006136169A2 (en) 2006-12-28
DE602006019961D1 (de) 2011-03-17
CY1112392T1 (el) 2015-12-09
LT5550B (lt) 2009-03-25
DK200900284A (da) 2009-02-27
JP4906852B2 (ja) 2012-03-28
SG169358A1 (en) 2011-03-30
EP1896439B2 (en) 2014-10-15
FI20077133A (fi) 2007-12-20
CN101189220A (zh) 2008-05-28
KR20080018191A (ko) 2008-02-27
SI1896439T1 (sl) 2011-03-31
AU2006261452B2 (en) 2010-02-04
RS51575B2 (sr) 2018-02-28
NO20080359L (no) 2008-01-18
TW201130808A (en) 2011-09-16
AU2006261452A1 (en) 2006-12-28
JP2008546724A (ja) 2008-12-25
MY143239A (en) 2011-04-15
EP1896439A2 (en) 2008-03-12
EP2325177A1 (en) 2011-05-25
GB2442160A (en) 2008-03-26
CZ300686B6 (cs) 2009-07-15
JP2012072168A (ja) 2012-04-12
RS51575B (en) 2011-08-31
KR20100133023A (ko) 2010-12-20
CA2612827C (en) 2010-11-30
DK200800075A (da) 2008-03-15
NO20101777L (no) 2008-01-18
AU2010200844A1 (en) 2010-04-01
CA2612827A1 (en) 2006-12-28
DK1896439T3 (da) 2011-02-28
CZ2007898A3 (cs) 2008-01-23
HUP0800135A2 (en) 2008-06-30
PL384185A1 (pl) 2008-06-23
KR20110084341A (ko) 2011-07-21
AT10983U1 (de) 2010-02-15
BG66086B1 (bg) 2011-03-31
ATE497500T1 (de) 2011-02-15
MY143252A (en) 2011-04-15
KR20120064140A (ko) 2012-06-18
LV13677B (en) 2008-05-20
IL187454A0 (en) 2008-02-09
LT2008005A (en) 2008-10-27
EP2385044A1 (en) 2011-11-09
PL1896439T5 (pl) 2016-01-29
EE00773U1 (et) 2008-10-15
EP1896439B1 (en) 2011-02-02
ES2319073A1 (es) 2009-05-01
SK500402007A3 (sk) 2008-05-06
JP2009046506A (ja) 2009-03-05
SI1896439T2 (sl) 2014-12-31
JP2009179634A (ja) 2009-08-13
ZA200711066B (en) 2009-07-29
IS8705A (is) 2008-01-14
ES2319073B1 (es) 2010-02-26
PT1896439E (pt) 2011-02-15
KR101340815B1 (ko) 2013-12-11
GB2442160B (en) 2010-01-20
JP2009179635A (ja) 2009-08-13
GB0811164D0 (en) 2008-07-23
KR20110033310A (ko) 2011-03-30
WO2006136169A3 (en) 2007-10-18
DE112006001619T5 (de) 2008-06-12
TR201000625T1 (tr) 2010-03-22
AR055062A1 (es) 2007-08-01
FI20080548A (fi) 2008-10-07
ZA200901698B (en) 2010-04-28
MX2007015328A (es) 2008-02-15
EA019239B1 (ru) 2014-02-28
ES2356838T5 (es) 2015-01-26
CA2646780A1 (en) 2006-12-28
CZ299906B6 (cs) 2008-12-29
GB2448834A (en) 2008-10-29
TWI347942B (en) 2011-09-01
GB2448834B (en) 2010-01-20
HUP0800135A3 (en) 2009-01-28
GB0724557D0 (en) 2008-01-23
CN101928269A (zh) 2010-12-29

Similar Documents

Publication Publication Date Title
AR079750A2 (es) Comprimidos bucodispersables y metodo de fabricacion
CY1120389T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει εναν glp-1-αγωνιστη, μια ινσουλινη και μεθειονινη
MX2009006917A (es) Agentes para combatir parasitos en animales.
MX2010008138A (es) Forma de dosis farmaceutica.
AR053466A1 (es) Un sistema de suministro para componentes activos como parte de una composicion comestible que incluye una relacion de material encapsulante y componente activo
CL2012000469A1 (es) Composición farmacéutica que comprende un compuesto conjugado de insulina de absorcion lenta; un envase; una suspensión que comprende la composición y su método de preparación; su uso para el tratamiento o prevención de una patología asociado a deficiencia de insulina, como diabetes; un kit.
AR063606A1 (es) Estabilizacion de vacunas mediante liofilizacion
EA200800415A1 (ru) Удаление пероксида из носителя для доставки лекарственного средства
HN2008001652A (es) Compuesto y composiciones como modulares de la senda de hedgehog
AR056751A1 (es) Composiciones pesticidamente activas que tienen actividad mejorada
EP2647692A3 (en) Compositions and methods comprising serine protease variants
GT200800276A (es) Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
NO20073065L (no) Injiserbare nanopartikulaere olanzapinformuleringer
CO6160335A2 (es) Vacuna
ECSP055800A (es) Composición farmacéutica que comprende micro-partículas de octreotida
AR076139A1 (es) Metodo para el tratamiento de cultivos con un pesticida encapsulado.
NO20075927L (no) IL-21 varianter
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
EA200800698A1 (ru) Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы
TW200738788A (en) Polyorganosiloxane composition for use in unsaturated elastomer, article made therefrom, and associated method
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
WO2007079312A3 (en) Compositions and methods for treating actin-mediated medical conditions
MX2009005817A (es) Agentes para combatir parasitos en animales.
DE602007001519D1 (de) Zusammensetzung mit mehreren botulinumtoxinen
AR060460A1 (es) Composicion para controlar la exposicion al oxigeno

Legal Events

Date Code Title Description
FA Abandonment or withdrawal